Analyst Jacob Armstrong of Stifel Nicolaus maintained a Buy rating on Elixirr International Plc (ELIX – Research Report), boosting the price target to p925.00.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Jacob Armstrong has given his Buy rating due to a combination of factors that highlight Elixirr International Plc’s robust financial performance and strategic growth initiatives. The company reported a significant 30% increase in revenue for FY24, driven by both organic and acquisitive growth, with a strong adjusted EBITDA margin of 28%. This financial strength is further supported by a solid balance sheet, with a net cash position of £7.5 million and free cash flow of £28 million.
Elixirr’s strategic plans to move to the LSE Main Market later in 2025 are expected to enhance its investor base and profile, potentially leading to inclusion in the FTSE 250, which would increase liquidity and capital access. The company’s four-pillar growth strategy, which includes expanding partner services, promoting and hiring partners, and strategic acquisitions, has been effectively executed. This, combined with a forward P/E ratio that represents a discount to historical averages, supports Armstrong’s positive outlook and Buy rating for the stock.